Abstract
Purpose: The incidence of prostate cancer is increasing in low-risk populations such as Japanese. One of the causes of this increase is considered to be associated with the Western diet, especially the high intake of red meat and fat. Glutathione S-transferase (GST) A1, T1, M1, and P1 are phase II enzymes that are important for activation and detoxification of chemical carcinogens.
Methods: In this study, 190 Japanese male patients with prostate cancer and 294 healthy controls, frequency-matched for age, were compared for frequencies of GSTA1, GSTT1, GSTM1, and GSTP1 genotypes.
Results: Among smokers, the frequency of the GSTA1*A/*B or *B/*B genotype in patients with prostate cancer (27.8%) showed a statistically significant increase compared with the control group frequency (18.2%; odds ratio [OR] =1.72; 95% CI, 1.01–2.94). In addition, the frequency of GSTT1 nondeletion genotype was associated with prostate cancer among smokers (OR =1.68; 95% CI, 1.06–2.68). The OR of carrying the combined genotyping of GSTA1*A/*B or *B/*B and GSTT1 nondeletion was 2.08 (95% CI, 1.14–3.80) with the combined genotyping of GSTA1*A/*A and GSTT1 null as a reference. On the other hand, no significant associations were observed for genotypes of GSTM1 and GSTP1 I105V.
Conclusions: These findings suggest that the GSTA1 and GSTT1 polymorphisms are associated with prostate cancer susceptibility, especially among smokers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ali-Osman F, Akanda O, Antoun G, Maso JX, Buolamwini J (1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNA of three human glutathione S-transferase Pi gene variants. J Biol Chem 272:10004–10021
Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, Green B, Lang NP, Kadlubar FF (2001) Effect of polymorphism in the human glutathione S-transferase A1 promotor on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 11:663–669
Gronberg H (2003) Prostate cancer epidemiology. Lancet 361:859–864
Guengerich FP, Thier R, Persmark M, Taylor JB, Pemple SE, Ketterer B (1995) Conjugation of carcinogens by theta class glutathione S-transferase: mechanisms and relevance to variations in human risk. Pharmacogenetics 5:S103–S107
Hallier E, Schroeder KR, Asmuth K, Donnermuth A, Aust B, Goergens HW (1994) Metabolism of dichloromethane (methylene chloride) to formaldehyde in human erythrocytes: influences of polymorphism of glutathione transferase theta (GSTT1-1). Arch Toxicol 68:423–427
Hayes RB, Ziegler RG, Gridley G (1999) Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev 8:25–34
Hickey K, Do K-A, Green A (2001) Smoking and prostate cancer. Epidemiol Rev 23:115–125
Jeronimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D (2002) I105 V polymorphism and promotor methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 11:445–450
Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, Ookuma R, Bell DA (1996) Glutathione S-transferaseM1(GSTM1) and T1(GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17:1855–1859
Kelada SR, Kardia SLR, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR (2000) The glutathione S-transferase-μ and -θ genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 9:1329–1334
Ketterer B, Harris JM, Talaska G, Meyer DJ, Pemble SE, Taylor JB, Lang NP, Kadlubar FF (1992) The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 98:87–94
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF (1994) Effect of human and rat glutathione S-transferase on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res 54:4920–4926
Morel F, Rauch C, Coles B, Ferrec EL, Guillouzo A (2002) The human glutathione transferase alpha locus: genomic organization of the gene cluster and functional characterization of the genetic polymorphism in the hGSTA1 promotor. Pharmacogenetics 12:277–286
Murata M, Wtanabe M, Yamanaka M, Kubota Y, Itoh H, Nagao M, Katoh T, Kamataki T, Kawanura J, Yatani R, Shiraishi T (2001) Genetic polymorphisms in cytochrome P450 (CYP)1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 165:171–177
Nelson CP, Kidd CR, Sauvageot J, Isaacs WB, De Marzo AM, Groopman JD, Nelson WG, Kensler TW (2001) Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res 61:103–109
Pemple S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Blot HM, Kettler B, Taylor JB (1994) Human glutathione S-transferase cθ (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271–276
Rebbeck TR, Walker AH, Jaffe JM, White DL, Wein AJ, Malkowicz SB (1999) Glutathione S-transferase-μ (GSTM1) and -θ (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev 8:283–287
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York, pp 9.1–9.62
Seidegard J, Vorachek WR, Pero RW (1998) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to gene deletion. Proc Natl Acad Sci USA 85:7293–7297
Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, Hasegawa R, Imaida K, Matsumoto K, Wakabayashi K, Sugimura T, Ito N (1997) The prostate: a target for carcinogenicity of 2-amino-1-metyl-6-phenylimidazo[4,5-b]pyridine(PhIP) derived from cooked foods. Cancer Res 57:195–198
Smith CJ, Perfetti TA, Rumple MA, Rodgman A, Doolittle DJ (2001) “IARC Group 2B carcinogen” reported in cigarette mainstream smoke. Food Chem Toxicol 39:183–205
Stuart GR, Holcroft J, Boer JG, Glickman BW (2000) Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 60:266–268
Veierod MB, Laake P, Thelle DS (1997) Dietary fat intake and risk of prostate cancer:a prospective study of 25708 Norwegian men. Int J Cancer 73:634–638
Watson MA, Stewart RK, Smith GBJ, Massey TE, Bell DA (1998) Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275–280
Acknowledgements
This work was supported in part by a grant-in-aid for risk analysis research on food and pharmaceuticals and cancer research from the Ministry of Health, Labour and Welfare of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Komiya, Y., Tsukino, H., Nakao, H. et al. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 131, 238–242 (2005). https://doi.org/10.1007/s00432-004-0634-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-004-0634-z